1. Standardization of imaging reads for eligibility assessment of patients—component of a risk mitigation strategy in the tanezumab clinical program. (April 2017) Authors: Roemer, F.W.; Miller, C.G.; West, C.R.; Sherlock, S.P.; Brown, M.T.; Kompel, A.J.; Diaz, L.; Galante, N.; Crema, M.D.; Guermazi, A. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗